Plant Health Care PLC
LSE:PHC
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Plant Health Care PLC
LSE:PHC
|
30.5m GBP |
Loading...
|
|
| US |
|
Corteva Inc
NYSE:CTVA
|
51.5B USD |
Loading...
|
|
| CA |
|
Nutrien Ltd
TSX:NTR
|
47.5B CAD |
Loading...
|
|
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
178.1B CNY |
Loading...
|
|
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
20.5B USD |
Loading...
|
|
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
130B CNY |
Loading...
|
|
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
15.7B USD |
Loading...
|
|
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR |
Loading...
|
|
| NO |
|
Yara International ASA
OSE:YAR
|
117.1B NOK |
Loading...
|
|
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
861.3B RUB |
Loading...
|
|
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
75.7B CNY |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Plant Health Care PLC
Glance View
Plant Health Care Plc engages in the provision biological products. The company is headquartered in Raleigh, North Carolina and currently employs 45 full-time employees. The company went IPO on 2004-07-06. The firm's segments include Americas, Mexico, and Rest of World. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. Its biological products help growers to protect their crops from stress and diseases. Its lead product, Harpin ab, is a recombinant protein developed from the naturally occurring Harpin proteins, which act as a biostimulant, promoting the yield and quality of crops. The company is also focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The company is developing six lead products from three platforms, including Innatus 3G platform, which targets growth and disease resistance; T-Rex 3G platform, which targets nematode defense, while the Y-Max 3G platform delivers increased yield and growth.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Plant Health Care PLC is 60.4%, which is below its 3-year median of 60.4%.
Over the last 3 years, Plant Health Care PLC’s Gross Margin has increased from 55.7% to 60.4%. During this period, it reached a low of 54.6% on Jun 30, 2021 and a high of 61.6% on Jun 30, 2022.
